— Know what they know.
Not Investment Advice

ALSPW.PA PAR

Spineway S.A.
1W: -5.9% 1M: -18.3% 3M: -18.4% YTD: -42.1% 1Y: -19.9% 3Y: -99.9% 5Y: -100.0%
€0.10 ($0.11)
-0.01 (-7.78%)
 
Weekly Expected Move ±7.3%
€0 €0 €0 €0 €0
PAR · Healthcare · Medical - Specialties · Tech Score Sell · Power 42 · €3.6M mcap · 36M float · 0.332% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap€3.6M ($4.1M)
52W Range0.102-0.256
Volume335,449
Avg Volume118,010
Beta0.27
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOStéphane Le Roux
Employees43
SectorHealthcare
IndustryMedical - Specialties
IPO Date2013-02-13
7, allEe Moulin Berger
Ecully, AR 69130
FR
33 4 72 77 01 52
About Spineway S.A.

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms